Search

everythinglearnresearchcommunity

for

Search:↓

Anti-TNF therapy can cause a unique type of hair loss that may get better with topical treatments without stopping the therapy.

Anti-TNF therapy can cause hair loss and skin issues.

Anti-TNF therapy can cause a rare hair loss condition similar to alopecia areata.

Anti-TNF-α therapy may increase the risk of developing alopecia areata, especially in those with a history of autoimmune disease.

A woman's rare scalp condition worsened after using a specific arthritis medication, suggesting such medications can sometimes trigger or aggravate psoriasis.

IBD patients treated with TNF antagonists may develop autoimmune alopecia areata, with severe cases less likely to improve.

Psoriasis patients on biologic therapy have a weaker immune response to COVID-19 vaccination than healthy people.

Acanthus ebracteatus Vahl. extract and verbascoside may help prevent hair loss and promote hair growth due to their anti-inflammatory properties and ability to protect against cell death.

Some drugs used to treat immune conditions may cause different types of hair loss.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

Certain immune system proteins are important for skin healing but can cause problems if there are too many of them.

Anti-IL17A therapy reduced venous leg ulcer size by 64% without major side effects.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Anti-IL-1 treatments might help with certain types of hair loss in people with high inflammation.

TNF-α blockers and IL inhibitors improve symptoms in most patients with severe scalp condition, but more research is needed.

Minor injuries to hair follicles can stimulate hair growth in mice by increasing a specific protein.

Lygodium japonicum spores can reduce inflammation by blocking certain cell signals.

Ficus carica leaf extract may help treat skin disorders by reducing inflammation and androgen effects in skin cells.

The article suggests that targeting specific immune pathways could help control and treat the skin disease hidradenitis suppurativa.

Future acne treatments should aggressively target inflammation to prevent scarring.

New methods to improve the healing abilities of mesenchymal stem cells for disease treatment are promising but need more research.

High TNF-α levels may increase hair loss risk after PRP therapy.

Certain hairstyles can cause scalp diseases, smoking is linked to hair loss, 5% minoxidil foam is effective for hair loss treatment, and various factors influence wound healing and hair growth.

Adalimumab helped control a child's severe eye disease when other treatments failed.

The document concludes that certain mutations may contribute to the inflammation in hidradenitis suppurativa and suggests that targeting TNFα could be a treatment strategy.

Diabetes can lead to blindness and skin problems, and managing blood sugar and blood pressure is crucial to prevent these complications.

New treatments like biologics and JAK inhibitors show promise for severe scalp inflammation when traditional methods fail.

TNFα, IFNγ, and Substance P significantly affect prolactin levels in human skin, suggesting new treatments for skin and hair conditions.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.